Patent · US Active

Process for the preparation of N-[(3-aminooxetan-3-yl)methyl]-2-(1,1-dioxo-3,5-dihydro-1,4-benzothiazepin-4-yl)-6-methyl-quinazolin-4-amine

US10005770B2 · kind B2 · utility

0Cited by
0References
31Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 21, 2016
Grant dateJun 26, 2018
Priority date
Expiry dateJul 21, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D305/08
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present invention relates to a novel process for the preparation of a compound of the formula (I): and pharmaceutically acceptable acid addition salts thereof, which is useful for prophylaxis and treatment of respiratory syncytial virus (RSV) infection in mammal or human being.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.